The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial-Reference-Cited by-同舟云学术

The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial

Published:2010-11 Issue:11 Volume:105 Page:2341-2346
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Moayyedi Paul,Armstrong David,Hunt Richard H,Lei Yao,Bukoski Margaret,White Robert J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2010368.pdf

Reference20 articles.

1. Review article: gastro-oesophageal reflux disease the extent of the problem.;Moayyedi;Aliment Pharmacol Ther,2005

2. How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices.;Hurenkamp;J Fam Pract,2002

3. Review article: gastro-oesophageal reflux disease - the health economic implications.;Mason;Aliment Pharmacol Ther,2005

4. Inappropriate prescribing of proton pump inhibitors in primary care.;Batuwitage;Postgrad Med J,2007

5. Gambling with gastroesophageal reflux disease: should we worry about the QALY?;Moayyedi;Am J Gastroenterol,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Pantoprazole on Kidney Outcomes;Journal of the American Society of Nephrology;2024-04-11

2. Association of proton pump inhibitor use with risk of kidney stones: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2007–2018);BMJ Open;2023-10

3. Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens;Current Issues in Molecular Biology;2023-05-29

4. Estudio comparativo de eficacia y seguridad de dexrabeprazol <i>versus</i> esomeprazol en el tratamiento de la enfermedad por reflujo gastroesofágico;Gaceta Médica de México;2022-10-20

5. Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey;Neurogastroenterology & Motility;2022-05-03